FR167653 Inhibits Bone Resorption Induced by Parathyroid Hormone Related Protein
Author Information
Author(s): Tao Huiren, Okamoto Mina, Nishikawa Masataka, Yoshikawa Hideki, Myoui Akira
Primary Institution: Osaka University Graduate School of Medicine
Hypothesis
Does FR167653 inhibit osteoclastogenesis and bone resorption induced by parathyroid hormone related protein (PTHrP)?
Conclusion
FR167653 effectively inhibits PTHrP-induced osteoclastogenesis and bone resorption in vitro and in vivo.
Supporting Evidence
- FR167653 inhibited PTHrP-induced osteoclast formation in vitro.
- Bone resorption area and osteoclast number in vivo were significantly decreased by FR167653 treatment.
- Whole blood ionized calcium levels were partially inhibited by FR167653.
Takeaway
This study shows that a drug called FR167653 can stop certain cells in the body from breaking down bones when a specific protein is present.
Methodology
The study involved in vitro assays with bone marrow cells and in vivo experiments with mice to assess the effects of FR167653 on osteoclast formation and bone resorption.
Potential Biases
Potential bias due to the use of animal models which may not fully replicate human physiology.
Limitations
The study does not explore the long-term effects of FR167653 on calcium homeostasis.
Participant Demographics
Male ddy mice and BDF1 mice were used in the experiments.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website